secwatch.observer — SEC 8-K summary
======================================

Issuer:     Astrana Health, Inc. (ASTH)
CIK:        0001083446
Form:       8-K
Filed at:   2024-03-11T23:59:59+00:00
Accession:  0001104659-24-032624
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Astrana Health issues FY2024 revenue $1.65-1.85B, Adj. EBITDA $165-185M
-----------------------------------------------------------------------

- FY2023 rev $1.39B, Adj. EBITDA $146.6M, diluted EPS $1.29.
- FY2024 guidance: rev $1.65-1.85B, Adj. EBITDA $165-185M, EPS $1.28-1.52.
- Closed CFC acquisition Jan 31, 2024; $202M total (cash $152M, equity $20M, milestones $30M).
- 10,000+ providers, ~900k VBC members; 48% fewer hospital admits vs benchmark.
- Care Enablement segment long-term EBITDA margin target 20-30%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1083446/000110465924032624/0001104659-24-032624-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1083446/000110465924032624/tm247913d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-032624

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer